These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1539851)

  • 1. Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding.
    Gravlee GP; Rogers AT; Dudas LM; Taylor R; Roy RC; Case LD; Triscott M; Brown CW; Mark LJ; Cordell AR
    Anesthesiology; 1992 Mar; 76(3):393-401. PubMed ID: 1539851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of different anticoagulation regimens on platelet function during cardiac surgery.
    Boldt J; Schindler E; Osmer C; Wittstock M; Stertmann WA; Hempelmann G
    Br J Anaesth; 1994 Nov; 73(5):639-44. PubMed ID: 7530029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management.
    Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass.
    Paparella D; Al Radi OO; Meng QH; Venner T; Teoh K; Young E
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):323-8. PubMed ID: 15970715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients.
    Despotis GJ; Filos KS; Zoys TN; Hogue CW; Spitznagel E; Lappas DG
    Anesth Analg; 1996 Jan; 82(1):13-21. PubMed ID: 8712388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postoperative heparin rebound following cardiopulmonary bypass.
    Pifarré R; Babka R; Sullivan HJ; Montoya A; Bakhos M; El-Etr A
    J Thorac Cardiovasc Surg; 1981 Mar; 81(3):378-81. PubMed ID: 7464201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig.
    Thelin S; Bagge L; Hultman J; Borowiec J; Nilsson L; Thorelius J
    Eur J Cardiothorac Surg; 1991; 5(9):486-91. PubMed ID: 1931093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
    von Segesser LK; Garcia E; Turina MI
    Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Adjusted Calculation Model of Reduced Heparin Doses in Cardiopulmonary Bypass Surgery in a Chinese Population.
    Zhang Y; Liu K; Li W; Xue Q; Hong J; Xu J; Wu L; Ji G; Sheng J; Wang Z
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1179-83. PubMed ID: 27475733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ulinastatin on coagulation and platelet function in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass].
    Ji HW; Chen L
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):175-8. PubMed ID: 19537033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.